BioCentury | May 10, 2019
Emerging Company Profile
HopeMed: Targeting PRLR for chronic diseases
...companies have disclosed developing PRLR inhibitors for endometriosis or alopecia. Xoma Corp., AbbVie Inc. and Oncolix Inc....
...Companies and Institutions Mentioned AbbVie Inc. (NYSE:ABBV), North Chicago, Ill. Bayer AG (Xetra:BAYN), Leverkusen, Germany Oncolix Inc....
...Targets PRL - Prolactin PRLR - Prolactin receptor Hongjiang Li, Staff Writer BAY 1158061 AbbVie Inc. Bayer AG Hope Medicine Inc. Oncolix Inc. Peking...
...Companies and Institutions Mentioned AbbVie Inc. (NYSE:ABBV), North Chicago, Ill. Bayer AG (Xetra:BAYN), Leverkusen, Germany Oncolix Inc....
...Targets PRL - Prolactin PRLR - Prolactin receptor Hongjiang Li, Staff Writer BAY 1158061 AbbVie Inc. Bayer AG Hope Medicine Inc. Oncolix Inc. Peking...
